Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2025-12-24 @ 11:37 PM
NCT ID:
NCT02329756
Eligibility Criteria:
Inclusion Criteria:
* Ultrasound and/or MRI diagnosed MAPL pregnancy scheduled to have a cesarean hysterectomy
* The responsible clinician is substantially uncertain as to whether or not to use TXA
* Consent has been given according to approved procedures
Exclusion Criteria:
* Women for whom the responsible clinician considers there is a clear indication for TXA should not be randomized
* Prior known thromboembolic event during pregnancy
* Known contraindication to TXA (prior adverse reaction)
* Patient unable to give adequate consent due to emergent cesarean hysterectomy
* Bleeding prior to incision
* Prior known thromboembolic event
* Women with a history of any acute venous or arterial thrombosis including retinal artery/retinal vein occlusion, cerebrovascular accident, myocardial infarction, deep venous thrombosis, pulmonary embolism
* History of decreased renal function, renal cortical disease, or significant renal tract disease.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
64 Years
Study:
NCT02329756
Study Brief:
Protocol Section:
NCT02329756